Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · third_quarter · Q3
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · second_quarter · Q2
Source: Senate LDA
Children Don't Belong on Tobacco Farms Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Cannabis Administration and Opportunity Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions. Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Marijuana Opportunity Reinvestment and Expungement Act
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Sentencing Reform and Corrections Act of 2017
Client: DRUG POLICY ALLIANCE · Firm: DRUG POLICY ALLIANCE
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
Opposing passage of the HALT Fentanyl Act (H.R. 467/S. 1141); Supported the Drug Policy Reform Act (H.R. 4020); Supporting reintroduction of the Cannabis Administration and Opportunity Act (CAOA) (S.4591)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2023 · first_quarter · Q1
Opposed passage of the HALT Fentanyl Act (H.R. 467); Supported the Drug Policy Reform Act (H.R. 4020)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · 2A
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · fourth_quarter · Q4
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions. Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · 3A
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · third_quarter · Q3
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · second_quarter · Q2
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2022 · first_quarter · Q1
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · fourth_quarter · Q4
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2021 · third_quarter · Q3
Supported federal marijuana reform, including the expungement and resentencing of cannabis convictions, lobbying on behalf of the MORE Act (HR 3617). Introduced and lobbied on behalf of the Drug Policy Reform Act (HR 4020).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · second_quarter · Q2
overdose, drug policy and criminal justice funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2019 · first_quarter · Q1
overdose, drug policy and criminal justice funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · fourth_quarter · Q4
Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · third_quarter · Q3
Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · second_quarter · Q2
Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.
S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2018 · first_quarter · Q1
S. 1764, CARERS Act, issues related to medical marijuana and ending federal marijuana prohibition. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.
Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · fourth_quarter · Q4
Issues related to marijuana spending amendments.
S. 1764, CARERS Act, issues related to medical marijuana. HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to overdose.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DRUG POLICY ALLIANCE via DRUG POLICY ALLIANCE
2017 · third_quarter · Q3
Issues related to marijuana spending amendments. Issues related to LEAD (DOJ) funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE